“AN IN-SILICO STUDY OF ANDALIMAN (Zanthoxylum acanthopodium DC.) AS AN ANTICANCER AGENT AGAINST TYROSINE KINASE ENZYME INHIBITION USING THE DOCKING METHOD: IN SILICO MOLECULAR DOCKING STUDY OF ACTIVE COMPOUNDS FROM ANDALIMAN (Zanthoxylum acanthopodium DC.) AGAINST TYROSINE KINASE ENZYME AS AN ANTICANCER AGENT”, fj, vol. 6, no. 1, pp. 348–372, July 2026, doi: 10.51771/fj.v6i1.2155.